跳至主要内容
临床试验/CTRI/2020/02/023151
CTRI/2020/02/023151尚未招募未知

To evaluate the in-vivo safety and efficacy of topical skin care formulation on psoriasis patients - Not Applicable

aCorium Health International Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects should have psoriasis affecting <20% of Body Surface Area.

排除标准

  • For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
  • Having refused to give his/her assent by signing the consent form
  • Taking part in another study liable to interfere with this study
  • Having history of cutaneous hypersensitivity
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
  • Ongoing use prohibited treatments (e.g. topical corticosteroids at least seven days on test site, systemic corticosteroids, oral anti psoriatic medication & Phototherapy at least four weeks.)

研究者

发起方
aCorium Health International Pvt Ltd

相似试验